Free Trial

SI-BONE Q1 2023 Earnings Report

SI-BONE logo
$13.25 +0.20 (+1.53%)
(As of 12/20/2024 05:16 PM ET)

SI-BONE EPS Results

Actual EPS
-$0.32
Consensus EPS
-$0.41
Beat/Miss
Beat by +$0.09
One Year Ago EPS
N/A

SI-BONE Revenue Results

Actual Revenue
$32.71 million
Expected Revenue
$29.20 million
Beat/Miss
Beat by +$3.51 million
YoY Revenue Growth
N/A

SI-BONE Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

SI-BONE Earnings Headlines

SI-Bone assumed with an Overweight at Morgan Stanley
⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
See More SI-BONE Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SI-BONE? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SI-BONE and other key companies, straight to your email.

About SI-BONE

SI-BONE (NASDAQ:SIBN), a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

View SI-BONE Profile

More Earnings Resources from MarketBeat

Upcoming Earnings